SCHEMBL7651877

SCHEMBL7651877

CCC(C)OC(=O)C(CC(=O)O)NCc1cccc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.52
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
KMT2A Q03164 2/20 0.49
PSMB5 P28074 1/20 0.45
CASP3 P42574 4/20 0.44
CASP6 P55212 4/20 0.44
CASP8 Q14790 4/20 0.44
CASP1 P29466 3/20 0.43
MME P08473 1/20 0.43
ACE P12821 1/20 0.43
CPA1 P15085 1/20 0.43
ACE2 Q9BYF1 1/20 0.43
MAPT P10636 2/20 0.42
ANPEP P15144 1/20 0.42
MEN1 O00255 1/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7654481 1.00 TDP1 (0.52) TDP1KDM4EALDH1A1KMT2APSMB5
SCHEMBL4878574 0.78 TDP1 (0.67) TDP1KDM4EALDH1A1KMT2APSMB5
SCHEMBL4878853 0.78 TDP1 (0.67) TDP1KDM4EALDH1A1KMT2APSMB5
SCHEMBL4878561 0.78 TDP1 (0.67) TDP1KDM4EALDH1A1KMT2APSMB5
SCHEMBL7654469 0.76 ALDH1A1 (0.50) TDP1KDM4EALDH1A1KMT2APSMB5
SCHEMBL7651872 0.76 ALDH1A1 (0.50) TDP1KDM4EALDH1A1KMT2APSMB5
SCHEMBL7387704 0.76 CTNNB1 (0.55) TDP1KDM4EALDH1A1KMT2AMME
SCHEMBL2355800 0.75 CDC25B (0.45) TDP1KDM4EALDH1A1KMT2AMAPT
SCHEMBL9729402 0.73 MAPT (0.40) TDP1MAPT
SCHEMBL1097611 0.72 KMT2A (0.56) TDP1KDM4EALDH1A1KMT2APSMB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6384061-B1 HYDANTOIN COMPOUNDS REPRESENTED BY FORMULA (I) WHICH SHOWS AN INHIBITORY ACTIVITY AGAINST FARNESYL TRANSFERASE, AND THUS CAN BE USED AS AN ANTI-CANCER AGENT, OR PHARMACEUTICALLY ACCEPTABLE SALTS LG CHEMICAL LTD. (KR) 2002-05-07 US disclosed